EPSMomentum

$ARWR with a neutral outlook following its earning release

NASDAQ:ARWR   Arrowhead Pharmaceuticals, Inc.
$ARWR released its earnings with a negative under reaction following its announcement with the PEAD projecting a neutral outlook and placing the stock in Drift D

If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.


Professional grade tools including Earning momentum and Post earning announcement drift price forecast. www.epsmomentum.com
Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.